- Report
- August 2025
- 96 Pages
Asia Pacific
From €3459EUR$3,950USD£3,003GBP
- Report
- September 2021
- 354 Pages
Global
From €3499EUR$3,995USD£3,037GBP
- Report
- November 2024
- 100 Pages
Global
From €2181EUR$2,490USD£1,893GBP
- Report
- October 2024
- 200 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- April 2023
- 147 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- September 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
Mast Cell Stabilizers are a type of respiratory drug used to treat asthma, allergic rhinitis, and other allergic conditions. They work by blocking the release of histamine and other inflammatory substances from mast cells, which are a type of white blood cell. This helps to reduce the symptoms of allergies and asthma, such as sneezing, wheezing, and difficulty breathing. Mast Cell Stabilizers are typically taken orally or inhaled, and are available in both prescription and over-the-counter forms.
Mast Cell Stabilizers are an important part of the respiratory drug market, as they can help to reduce the severity of allergic reactions and asthma symptoms. They are often used in combination with other medications, such as corticosteroids and bronchodilators, to provide more comprehensive relief.
Some companies in the Mast Cell Stabilizer market include GlaxoSmithKline, Merck, Novartis, and Sanofi. Show Less Read more